| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |